Industry Overview

Global Extractables and Leachables Testing Services Market is expected to reach US$ 4716.2 Mn. by 2027, at a CAGR of 6.1% during the forecast period. Pharmaceutical companies are developing new drugs and excipients policies that play a crucial role in patient safety. FDA and Europe union health policies on pharmaceutical product release are stringent which ensures the safety of the patients. The European Medicines Agency (EMA) is increasingly focusing on the interactions between various manufacturing components, drug delivery devices and container-closure systems (CCS), and the final pharmaceutical product. The aim is to identify and assess any toxicological risks which could arise via such interactions. The drug contains a harmful chemical that is contagious in the stage of primary packaging that may cause a serious threat to the patients if the patients use these products. Thus, the migration of pharmaceutical products is extremely important at the early stage this has led to the increasing demand for Extractables and Leachables Testing Services to ensure patient safety.